Left atrial appendage exclusion: State-of-the-art

Catheterization and Cardiovascular Interventions

Volumn 75, Issue 5, 2010, Pages 806-813

  Cruz Gonzalez, Ignacio ^a   Yan, Bryan P ^b,c   Lam, Yat Yin ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Atrial fibrillation; Left atrial appendage exclusion; Oral anticoagulation; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CLOPIDOGREL; HEPARIN; WARFARIN;

AIR EMBOLISM; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD VESSEL PERFORATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STROKE; THROMBOEMBOLISM; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADMINISTRATION, ORAL; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; SEPTAL OCCLUDER DEVICE; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 77950420292     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22344     Document Type: Article

References (20)

1. Sacco RL, Benjamin EJ, Broderick JP, et al. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-1517.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
3. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
4. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867.
5. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Eur Heart J 2006;27:1979-2030.
6. Onalan O, Lashevsky I, Hamad A, Crystal E. Nonpharmacologic stroke prevention in atrial fibrillation. Expert Rev Cardiovasc Ther 2005;3:619-633.
7. Bungard TJ, Ackman ML, Ho G, Tsuyuki RT. Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital. Pharmacotherapy 2000;20:1060-1065.
8. Su P, Mccarthy KP, Ho SY. Occluding the left atrial appendage: Anatomical considerations. Heart 2008;94:1166-1170.
9. Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, Seward JB, Tajik AJ, Edwards WD. Anatomy of the normal left atrial appendage: A quantitative study of age-related changes in 500 autopsy hearts: Implications for echocardiographic examination. Circulation 1997;96:3112-3115.
10. Themistoclakis S, Rossillo A, Bonso A, Raviele A. Intracardiac echocardiography for implantation of LAA occlusion devices: A further step toward the ICE era? Heart Rhythm 2007;4:572-574.
11. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 2002;105:1887-1889.
12. Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005;46:9-14.
13. Ussia GP, Mule M, Cammalleri V, Scarabelli M, Barbanti M, Imme S, Mangiafico S, Marchese A, Galassi AR, Tamburino C. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation. Catheter Cardiovasc Interv 2009;74:217-222.
14. Park JW, Leith Auser B, Gerk U, Vrsansky M, Jung F. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. J Invasive Cardiol 2009;21:446-450.
15. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (percutaneous left atrial appendage transcatheter occlusion) Study. JACC Cardiovasc Interv 2009;2:594-600.
16. Chiam PT, Ruiz CE. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation. J Invasive Cardiol 2008;20:E109-E113.
17. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-1495.
18. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-542.
19. Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: A transesophageal echocardiograhic study. J Am Coll Cardiol 2000;36:468-471.
20. Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV. Thoracoscopic extra-cardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003;42: 1249-1252.